Viatris VTRS
NASDAQ VTRS
$16.10 -0.14 (-0.86%)
At close: Aug 20, 2026 · 2:00 PM UTC

Viatris (VTRS) Net Margin Growth (1y) (2020 - 2026)

Viatris (VTRS) Net Margin Growth (1y) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Haleon 43.94 Bn 42.97 Bn - -
2 Teva Pharmaceutical Industries 42.95 Bn 39.30 Bn 2.15 Bn -2,064.00
3 Zoetis 31.58 Bn 29.90 Bn 1.05 Bn -177.00
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -195.00
5 United Therapeutics 22.16 Bn 19.49 Bn 683.80 Mn 376.00
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn -303.00
7 Neurocrine Biosciences 15.53 Bn 15.14 Bn 935.80 Mn -58.00
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn 306.00
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn - -
10 Alkermes 8.12 Bn 7.46 Bn 397.90 Mn -2,219.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -303.00
Mar 31, 2026 9,850.00
Dec 31, 2025 574.00
Sep 30, 2025 -594.00
Jun 30, 2025 849.00
Mar 31, 2025 -9,659.00
Dec 31, 2024 532.00
Sep 30, 2024 -590.00
Jun 30, 2024 -1,536.00
Mar 31, 2024 -292.00
Dec 31, 2023 -4,600.00
Sep 30, 2023 -28.00
Jun 30, 2023 -91.00
Mar 31, 2023 -353.00
Dec 31, 2022 3,184.00
Sep 30, 2022 182.00
Jun 30, 2022 1,377.00
Mar 31, 2022 3,314.00
Dec 31, 2021 1,928.00
Mar 31, 2021 -2,438.00